- Published at
- by globenewswire.com
mixed
mixed
Biopharmaceutical CMO Market Size Expected to Reach USD 58.2 Billion by 2032 with 16.0% CAGR - SNS Insider
Driven by Demand for Outsourced Biologics Production, the Biopharmaceutical Contract Manufacturing Organization (CMO) Market Surges with Expansion in...